ArticleCureus2025
Removal of Prostate Calcifications Prior to TULSA-PRO With the Aid of Real-Time Ultrasound Imaging: Our Technique and Experience.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transurethral ultrasound ablation for prostate cancer: MRI-based pre-treatment planning and post-treatment assessment-what the radiologist needs to know.Abdominal radiology (New York) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Prostate calcifications can impede ultrasound energy propagation during transurethral ultrasound ablation (TULSA-PRO, Profound Medical Inc., Mississauga, ON, Canada). We instituted a pre-procedure screening protocol using low-dose pelvic computed tomography (CT) with ≤2-mm slices to detect calcifications larger than 3 mm along the planned ablation path; when obstructing deposits are present, we clear them immediately before treatment. Drawing on image-guided principles used in Aquablation (AquaBeam Robotic System, PROCEPT BioRobotics, San Jose, CA, USA), we correlate preoperative sagittal CT with real-time, stepper-mounted transrectal ultrasound (TRUS) to localize targeted prostate tissue for limited bipolar resection, while continuously visualizing the loop position on TRUS. In eight consecutive candidates with obstructive calcifications ≥3 mm, post-procedure low-dose CT confirmed clearance in every case, enabling uninterrupted continuation to the TULSA-PRO workflow. This streamlined, CT-referenced, TRUS-guided technique offers a practical pathway to preserve beam-path integrity without broad tissue debulking. The dataset of eight consecutive candidates with obstructive calcifications ≥3 mm reported here is original and has not been previously published in whole or in part.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.